SLC16A3 and breast cancer: A total of 27 upregulated (ACHE[11], HSPA1L[12], NES[13], P2RY2[14], PLCG1[15], PPARGC1A[16], PRKCQ[17], SNTA1[18], ALDOA[19], GNAO1[20], SLC16A3[21], TPI1[22], ELL2[23], CCNG1[24], E2F6[25], ESRRG[26], MAPK12[27], HSD17B7[28], TACC2[29], DDX1[30], MYH1[31], UCP1[32], PACSIN3[33], PGM1[34], TLN2[35], ADIPOR1[36], PITX1[37]) and 8 downregulated genes (CELSR2[38], PRKCB[39], KIT[40], MAP2[41], TDGF1[42], ELF1[43], RUNX1[44], TYMS[45]) showed association with breast cancer.